| Literature DB >> 30966707 |
Abstract
The present work envisages a simple approach to synthesize a new wound dressing based on chitosan-dialdehyde cellulose nanocrystal-silver nanoparticles (CS-DCNC-AgNPs). Silver nanoparticles (AgNPs) were generated in-situ by periodate oxidation of cellulose nanocrystals to generate aldehyde functions, which were used to reduce Ag⁺ into Ag⁰ in mild alkaline conditions. Subsequently, the dialdehyde cellulose nanocrystal-silver nanoparticles (DCNC-AgNPs) were added to chitosan (CS) to form the wound dressings by solution casting method. The aim was to enhance the antibacterial effect of CS by incorporation of AgNPs and to improve the mechanical strength and hydrophobicity of CS by incorporation of DCNC that cross-linked by hydrogen bonds. The antibacterial activities were evaluated against five gram-negative bacteria, one gram-positive bacteria, and three fungi. The in vitro cytotoxicity assay was performed using the NIH3T3 cell lines by Sulforhodamine B assay. Research outputs signified that CS-DCNC-AgNPs possessed good mechanical strength and hydrophobicity, high antibacterial activity and less cytotoxicity. Our results propose that CS-DCNC-AgNPs can be a promising, safe antibacterial to be incorporated in wound dressings.Entities:
Keywords: antibacterial activity; chitosan; cytotoxicity; dialdehyde cellulose nanocrystals; mechanical strength; silver nanoparticles; wound dressings
Year: 2018 PMID: 30966707 PMCID: PMC6404142 DOI: 10.3390/polym10060673
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Characterization of DCNC-AgNPs and CS- DCNC-AgNPs: (a) UV-Vis absorption spectra of DCNC-AgNPs. The figure in the inset shows the color of synthesized DCNC-AgNPs. (b) TEM image of DCNC-AgNPs. (c) XPS spectra of CS-DCNC-AgNPs. (d) FTIR spectra of CS- DCNC-AgNPs.
Figure 2SEM image of the cross-section: (a) CS. (b) CS-DCNC-AgNPs (3%). (c) CS-DCNC-AgNPs (5%). (d) CS-DCNC-AgNPs (10%).
Mechanical strength of CS-DCNC-AgNPs.
| Material | Tensile strength (MPa) | Tensile modulus (MPa) | Elongation at break (100%) | |||
|---|---|---|---|---|---|---|
| Dry | Wet | Dry | Wet | Dry | Wet | |
| CS | 48.5 ± 6.3 | 0.9 ± 0.2 | 1688 ± 153 | 0.7 ± 0.3 | 34.2 ± 5.3 | 65.2 ± 7.3 |
| CS-DCNC-AgNPs (3%) | 49.6 ± 3.5 | 1.5 ± 0.3 | 1931 ± 146 | 3.5 ± 0.4 | 22.4 ± 6.7 | 42.7 ± 9.4 |
| CS-DCNC-AgNPs (5%) | 54.2 ± 4.3 | 3.3 ± 0.6 | 2155 ± 182 | 5.9 ± 0.6 | 17.5 ± 4.6 | 34.3 ± 5.7 |
| CS-DCNC-AgNPs (10%) | 54.4 ± 5.4 | 3.9 ± 0.4 | 2263 ± 204 | 6.3 ± 0.5 | 15.2 ± 6.1 | 30.5 ± 4.8 |
Figure 3Swelling ratio of CS with varying DCNC-AgNPs concentration.
Figure 4Antibacteria activity of CS-DCNC-AgNPs: (A) Gram-positive bacteria, (B) Gram-negative bacteria, (C) fungi. The meaning of the letter in the inset is: (a) CS, (b) CS-DCNC-AgNPs (3%), (c) CS-DCNC-AgNPs (5%), (d) CS-DCNC-AgNPs (10%).
Figure 5RGR values and cytotoxicity level of CS-DCNC-AgNPs: toxicity level 0 and I represent safe.